pharma holding inc.

283 commack road
commack, new york 11725

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 02, 2014

NYS DOS ID#
4600945

County
KINGS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - PHARMA HOLDING INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • NY's Hometown Paper Once Again Owned By Chicago Publisher
    Tuesday Sep 5, 2017

    New York's hometown paper is once again owned by a Chicago-based newspaper holding company, following the 'New York Daily News' sale on Monday to Tronc Inc. In a way, it's like deja vu. Tronc wasformerly Tribune Publishing, the publisher of the 'Chicago Tribune,' which originally created the 'New York Daily News' nearly a century ago.

    Source: Media Post: MediaDailyNews
  • Amid Opioid Crisis, Insurers Restrict Pricey, Less Addictive Painkillers
    By KATIE THOMAS and CHARLES ORNSTEIN - Monday Sep 18, 2017

    Drug companies and doctors have been accused of fueling the opioid crisis, but some question whether insurers have played a role, too.

    Source: NYT > Home Page
  • Trailer Bought To Hold Victims Of Terrorism Now Holds Victims Of Heroin Overdoses
    By Laura Northrup - Monday Jun 26, 2017

    In 2012, St. Louis County in Missouri used a grant from the Department of Homeland Security to buy a refrigerated trailer that can hold more than 20 human bodies. The trailer was intended for use after a terrorist attack or natural disaster, and the county is fortunate that the money spent to buy it was wasted. Until now, when the …

    Source: The Consumerist
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • Martin Shkreli, ‘Pharma Bro,’ Prepares for Trial: ‘I’m So Innocent’
    By STEPHANIE CLIFFORD - Thursday Jun 22, 2017

    The former hedge fund manager, vilified by the public and politicians after increasing the price of a prescription drug, is facing eight counts of securities and wire fraud.

    Source: NYT > Home Page